Born in Piacenza, Italy 21 July 1972
Education
2005 Ph.D. in Pharmacology and Toxicology at the University of Parma, ITALY, discussing a thesis titled: “Study on cellular lipid efflux mechanisms and their pharmacological modulation”
1999-2004 Researcher at the Institute of Pharmacology and Pharmacognosy, Laboratory of Cellular Pharmacology, Faculty of Pharmacy, University of Parma, ITALY
1997 Doctor of Pharmaceutical Chemistry and Technology, University of Parma, ITALY.
1995-1997 Internal student at the Institute of Pharmacology and Pharmacognosy, University of Parma, Faculty of Pharmacy, Laboratory of Cellular Pharmacology of Atherosclerosis.
1991 Registered at Faculty of Pharmacy to “Pharmaceutical Chemistry and Technology” program at the University of Parma.
Curriculum Of Career
2014-present Associate Professor of Pharmacology, Department of Pharmacy firs and then Food and Drug, University of Parma, ITALY.
2004-2014 Researcher Assistant Professor (Aggregate Professor), Department of Pharmacy, University of Parma, ITALY.
1999-2004 Winner of fellowship as researcher disposed by Italian Ministry of Research at the Institute of Pharmacology and Pharmacognosy, Faculty of Pharmacy, University of Parma, ITALY
1998-1999 Winner of a fellowship Grant on the National Drugs Project, ITALY
Foreign Experiences
2000-2002 Visiting Scientist at Children's Hospital of Philadelphia, Philadelphia, USA, to study the mechanisms of atherogenesis and the reverse cholesterol transport (RCT).
2007 Invited by Prof. G. Rothblat at J. Stokes Jr. Research Institute at the Children's Hospital of Philadelphia to give scientific seminar on "Lipoprotein acceptors and cellular cholesterol efflux: insights from genetic HDL disorders".
Research Interest
Physiology and pharmacology of atherosclerosis and cholesterol metabolism with particularly interest to cellular cholesterol efflux processes. Prof. Favari has an experience in evaluating cholesterol metabolic processes at cellular level and cholesterol efflux capacity. She provided different contributions to the elucidation of the process of reverse cholesterol transport. The research activity of Prof. Favari has been carried out in collaboration with Italian and foreign research groups (USA, Australia, Great Britain, Switzerland, Holland) and has led to several productions of scientific relevance, for a total of more than 50 scientific papers in international peer reviewed journals.
Scientific collaborations
Most important national and international scientific collaborations: Prof. LAURA CALABRESI: University of Milan, Milan; Prof. SEBASTIANO CALANDRA: University of Modena and Reggio Emilia, Modena; Prof. DANIEL J READER Department of Genetics and Medicine, Cardiovascular Institute, and Institute for Translational Medicine and Therapeutics, University of Pennsylvania, Philadelphia, PA, USA; Prof. MARY SORCY-THOMAS, Departments of Medicine, Section on Endocrinology, Medical College of Wisconsin, Milwaukee, WI, USA; Prof. WENDY JESSUP, Center for Vascular Research, University of New South Wales, Sidney, Australia; Dr. NICOLAS VUEILLUMIERE, Division of Laboratory Medicine, Department of Genetics and Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland; Prof. CLAUDIA STEFANUTTI, La Sapienza University of Rome, Rome; Dr. LIVIA PISCIOTTA, University of Genoa, Genoa.
Reviewer activity
Reviewer for the following scientific journals: Circulation, Lipids, Biochemical Journal, Atherosclerosis, Nutrition Metabolism and Cardiovascular Disease (NMCD). Academic Editor of the journal Medicine.
Awards, Membership And Meetings
2000-Grant from AstraZeneca at the XX National Congress SISA
2011-National Research Grant from Gruppo Italiano per la Lotta contro il Lupus Eritematoso Sistemico (LES)
Member of the Italian Society of Pharmacology (SIF) and Italian Society of Atherosclerosis (SISA) of which she was a member of the executive committee of the Emilia Romagna regional section from 2007 to 2013, scientific secretary from 2007 to 2010 and founder of the group of the SISA Youth from 2013 to 2015. Since 2015 an active member of the Mighty Medic Company. Member of the International Society of Arteriosclerosis (IAS) and European Lipoprotein Club (ELC). Prof. Favari participated at several national and international scientific meetings with also invited oral presentations.
Grants Achieved
1997-2000 National Drugs Project
1999 Project funded by the European Community QLG1-1999-01007 “MAFAPS: Macrophage function and stability of the atherosclerotic plaque”.
2001 FIRB (PNR 2001-2003) “Nuove strategie per la prevenzione e il controllo dell'ischemia cerebrale su base vascolare: ruolo dei meccanismi infiammatori e proteolitici”.
2000-2002 PRIN MM06178194_007 “FAMILIAL HIGH DENSITY LIPOPROTEIN (HDL) DEFICIENCY. GENETIC, BIOCHEMICAL AND CLINICAL FEATURES”.
2005-2007 PRIN 2005061114_005 “REGOLAZIONE GENETICA E FARMACOLOGICA DEL TRASPORTO INVERSO DEL COLESTEROLO”.
2009 Regional Project of EMILIA ROMAGNA “DiAL-ER/ ADSL: Diagnostica Avanzata in Lipidologia – Emilia Romagna/ Advanced Diagnostic Support in Lipidology. Project Title: “role of genotypic, phenotypic and functional evaluation of lipoproteins in dislipidemias”.
2009 Cariplo Foundation “Ricerca Scientifica in ambito biomedico” Title: “HDL QUANTITY OR QUALITY TO IMPROVE CARDIOVASCULAR PREVENTION: INSIGHTS FROM INHERITED HDL DISORDERS”.
2009 European COST Action BM0904 HDL-From Biological Understanding to Clinical Exploitation.
2012 Cariplo Foundation “Ricerca Medica 2012” Title: “Investigating the role of pro-protein convertase subtilisin/kexin type 9 (PCSK9) released from smooth muscle cells on atherogenesis”.
2013 Scientific project financed by Rottapharm SpA. In vivo effect of red yeast rice, policosanols and berberine on the antiatherogenic process of reverse cholesterol transport and on systemic inflammation.
Scientific collaborator of several research contracts with companies: Fournier, Glaxo, Recordati, Sigma-Tau, Kowa, Roche, Astrazenaca, AbbVie.
2015- Scientific manager of research contract with Aegerion, Amryt Pharma, Kaneka Corporation.
Scientific committees
Member of scientific committees for the organization of the following congresses: XI SISA Convention Emilia Romagna Regional Section “IL RISCHIO CARDIOVASCOLARE: NUOVE ACQUISIZIONI E PROSPETTIVE”, Parma, November 4th 2011; XII SISA Convention Regional Section Emilia Romagna, Ravenna, 10 November 2012; CONVEGNO MONOTEMATICO DELLA SIF “NUOVE FRONTIERE NELLA TERAPIA DELL'ATEROSCLEROSI”, Milan, 3 February 2012; 7th International Atherosclerosis Society Congress - Sponsored Workshop on HDL, Rome, 2014. In 2016 member of the organizing committee of the Spring Meeting of the Young Researchers groups of SIIA (Italian Society of Arterial Hypertension) and SISA (Italian Society for the Study of Atherosclerosis) “Ipertensione arteriosa, dislipidemie ed aterosclerosi: nuovi links fisiopatologici e terapeutici”, Rimini. In 2017, together with his colleague Dr. Pisciotta of the scientific workshop "DYSLIPIDEMIAS AND LIPOPROTEIN METABOLISM" in the context of the 51st Annual Scientific Meeting of the EUROPEAN SOCIETY FOR CLINICAL INVESTIGATION (ESCI), Genoa.
Publications and Bibliometric indexes
Prof. Favari published 50 articles in peer-reviewed journals.
H-index: 23.
Author of 25 works in the last 5 years, 9 of which in international collaborations and 22 in journal placed in the top 25% (Q1) for Cite Score.
In the last 15 years: 43 publications in indexed journals, of which 16 in magazines placed in the top 10% (Q1) for Cite Score, for a total of 1070 citations, an H-index of 20 (15 years) and a normalized impact of 1.66 (1.68 international media)
International Filing of patent application entitled “New MDR1 inhibitors for overcoming multidrug Resistance”
Number: PCT/EP2015/067795
Filing date: August 4, 2015
Institutional assignments
Qualified as Associate Professor ASN Bando 2012 (DD n.222 / 2012). Associate Professor at the University of Parma since 2014. Delegate for “Student Orientation” at the Department of Food and Drug, University of Parma.
Teaching activity
Prof. Favari collaborated form 2003 for the Toxicology course for the degree in Pharmaceutical Chemistry and Technology. 2004-2005 she was in charge of the Toxicology course for the degree in "Health Products". She was in charge of the Toxicology course for the degree in Herbal Sciences and Health Products for the academic years 2005-2006; 2006-2007; 2007-2008; 2008-2009; 2009-2010; 2011-2012. She was in charge of the course of Anticancer chemotherapy and new therapies for the School of Specialization in Hospital Pharmacy for the academic years 2011-2012, 2012-2013 and 2013-2014. She was in charge of the "Pharmacovigilance" course for the degree in Pharmacy for the academic year 20012-2013 and 2013-2014.
Since 2014 he is the owner of the Toxicology course for the degree in Pharmacy at the Department of Food and Drug, University of Parma. She has been speaker of several experimental theses for the Degree in Pharmaceutical Chemistry and Technology and “Biotecnologie per la salute”. Since 2007 she has been a member of the board of professors for the PhD course in PHARMACOLOGY AND EXPERIMENTAL TOXICOLOGY of the Faculty of Pharmacy and of the Department of Pharmacy of the University of Parma. From 2013 she is a member of the faculty board of the PhD in Drugs, Biomolecules and Health Products at the Department of Food and Drug, University of Parma. From 2014 member of the Teaching College of the School of Specialization in Hospital Nephrology.
Invited lecturer in European courses at ULLA SUMMER SCHOOL, in Parma in 2011 and in Paris in 2015.
